These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18987785)

  • 21. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
    Matsuura E; Kobayashi K; Tabuchi M; Lopez LR
    Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative hypothesis of atherogenesis.
    Klatt P; Esterbauer H
    J Cardiovasc Risk; 1996 Aug; 3(4):346-51. PubMed ID: 8946263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.
    Binder CJ; Hörkkö S; Dewan A; Chang MK; Kieu EP; Goodyear CS; Shaw PX; Palinski W; Witztum JL; Silverman GJ
    Nat Med; 2003 Jun; 9(6):736-43. PubMed ID: 12740573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibodies against low density lipoprotein with various degrees of oxidative modifications.
    Gidlund ; Damasceno NR; Lindoso JA; Abdalla DS; Goto H
    Braz J Med Biol Res; 1996 Dec; 29(12):1625-8. PubMed ID: 9222422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a specific monoclonal antibody 9F5-3a and the development of assay system for oxidized HDL.
    Nakajima T; Sakagishi Y; Katahira T; Nagata A; Kuwae T; Nakamura H; Inoue I; Takahashi K; Katayama S; Komoda T
    Biochem Biophys Res Commun; 1995 Dec; 217(2):407-11. PubMed ID: 7503715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients?
    Pawlak K; Mysliwiec M; Pawlak D
    Life Sci; 2013 Mar; 92(4-5):253-8. PubMed ID: 23295961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-oxidized low-density lipoprotein antibodies in myeloperoxidase-positive vasculitis patients preferentially recognize hypochlorite-modified low density lipoproteins.
    Slot MC; Theunissen R; van Paassen P; Damoiseaux JG; Tervaert JW;
    Clin Exp Immunol; 2007 Aug; 149(2):257-64. PubMed ID: 17521320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The preparation of copper-oxidized LDL for the measurement of oxidized LDL antibodies by EIA.
    Lopes-Virella MF; Koskinen S; Mironova M; Horne D; Klein R; Chassereau C; Enockson C; Virella G
    Atherosclerosis; 2000 Sep; 152(1):107-15. PubMed ID: 10996345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation.
    Itabe H; Obama T
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease.
    Toshima S; Hasegawa A; Kurabayashi M; Itabe H; Takano T; Sugano J; Shimamura K; Kimura J; Michishita I; Suzuki T; Nagai R
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2243-7. PubMed ID: 11031210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease.
    Andican G; Seven A; Uncu M; Cantaşdemir M; Numan F; Burçak G
    Scand J Clin Lab Invest; 2008; 68(6):473-8. PubMed ID: 18609113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody.
    Itabe H; Yamamoto H; Imanaka T; Shimamura K; Uchiyama H; Kimura J; Sanaka T; Hata Y; Takano T
    J Lipid Res; 1996 Jan; 37(1):45-53. PubMed ID: 8820101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidation of LDL and its clinical implication.
    Matsuura E; Hughes GR; Khamashta MA
    Autoimmun Rev; 2008 Jul; 7(7):558-66. PubMed ID: 18625445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?
    Verhoye E; Langlois MR;
    Clin Chem Lab Med; 2009; 47(2):128-37. PubMed ID: 19099526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient increase in plasma oxidized LDL during the progression of atherosclerosis in apolipoprotein E knockout mice.
    Kato R; Mori C; Kitazato K; Arata S; Obama T; Mori M; Takahashi K; Aiuchi T; Takano T; Itabe H
    Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):33-9. PubMed ID: 18988894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catabolism of native and oxidized low density lipoproteins: in vivo insights from small animal positron emission tomography studies.
    Pietzsch J; Bergmann R; Wuest F; Pawelke B; Hultsch C; van den Hoff J
    Amino Acids; 2005 Dec; 29(4):389-404. PubMed ID: 16012780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients.
    Girona J; Manzanares JM; Marimón F; Cabré A; Heras M; Guardiola M; Ribalta J; Masana L
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):380-7. PubMed ID: 17904830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of hypercholesterolemia on serum antibodies against oxidized LDL in children and adolescents.
    Garoufi A; Marmarinos A; Vraila VM; Dimou S; Pagoni A; Vorre S; Paraskakis I; Gourgiotis D
    Pediatr Int; 2018 Mar; 60(3):287-293. PubMed ID: 29297961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Esterified lipid hydroperoxide-derived modification of protein: formation of a carboxyalkylamide-type lysine adduct in human atherosclerotic lesions.
    Kawai Y; Fujii H; Kato Y; Kodama M; Naito M; Uchida K; Osawa T
    Biochem Biophys Res Commun; 2004 Jan; 313(2):271-6. PubMed ID: 14684156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis.
    Sämpi M; Ukkola O; Päivänsalo M; Kesäniemi YA; Binder CJ; Hörkkö S
    J Am Coll Cardiol; 2008 Oct; 52(17):1370-8. PubMed ID: 18940525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.